Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study.
about
Purification and mechanism of human aldehyde oxidase expressed in Escherichia coliGenetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study.Aldehyde oxidase and its importance in novel drug discovery: present and future challenges.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Structure and function of mammalian aldehyde oxidases.
P2860
Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@en
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@nl
type
label
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@en
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@nl
prefLabel
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@en
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@nl
P1476
Drugs that inhibit oxidation r ...... iprasidone: an in vitro study.
@en
P2093
R Scott Obach
Robert L Walsky
P304
P356
10.1097/01.JCP.0000186740.22395.50
P407
P577
2005-12-01T00:00:00Z